Outcome of EGM

| Updated on November 14, 2017 Published on March 19, 2012

Titan Biotech Ltd has informed BSE that the shareholders at the Extra Ordinary General Meeting (EGM) of the Company held on March 13, 2012, have considered and approved the following business:

1. The Shareholders has accorded their consent to issue 15,00,000 (Fifteen Lacs only) Equity Shares of face value of Rs. 10/- each on a preferential basis to the non promoters at a premium of Rs. 10/- each (offer price would be Rs. 20 per share) subject to the terms of SEBI Preferential Issue Guidelines and other applicable regulations.

2. As directed by the Stock Exchange, while granting the In principle Approval for the above allotment, the relevant date has been revised from February 13, 2012 to February 10, 2012. The circular and the intimation has been noted in the meeting.

Source : BSE - >www.bseindia.com

Published on March 19, 2012
This article is closed for comments.
Please Email the Editor